Transfusion medicine company Grifols revealed on Tuesday the receipt of approval from the US Food and Drug Administration approval for Erytra Eflexis, a fully automated, benchtop blood typing analyzer.
Following the US FDA approval, Erytra Eflexis expands the company's portfolio of blood typing solutions and can be used as a stand-alone system or in combination with other Grifols blood typing portfolio solutions.
Grifols added that the Erytra Eflexis system performs pretransfusion compatibility testing using DG Gel technology. It incorporates two lab configurations in a single instrument so laboratories can select the solution best suited to various workflow needs and capacities. The Interchangeable sample and reagent linear racks allow easy, continuous loading of cards, reagents and samples.
According to the company, Erytra Eflexis features real random access with a capacity of up to 200 cards, 72 samples and 46 liquid reagents. The transparent casing provides a clear view of the simple internal organisation and processes.
This smart, flexible and intuitive system optimises workflow efficiency and improves daily workloads, providing laboratories with a high level of flexibility and adaptability. It is designed for enhanced quality control to support improved patient care, concluded the company.
AbbVie's ELAHERE receives full US FDA approval
Johnson & Johnson's OPSYNVI receives US FDA approval
Outlook Therapeutics receives positive CHMP opinion for ONS-5010 in wet AMD treatment
Human Immunology Biosciences receives ODD from FDA for felzartamab
Eton Pharmaceuticals acquires PKU GOLIKE, expanding rare disease portfolio
Vertex receives FDA clearance for VX-407 Investigational New Drug Application for ADPKD
Phanes Therapeutics receives FDA Fast Track designation for PT886
Bio-Thera Solutions signs new licensing agreement with SteinCares
FDA accepts resubmission of Citius Pharmaceuticals, Inc's BLA for LYMPHIR
GSK Plc reports positive Phase III Jemperli data for endometrial cancer
ImmVira receives FDA Fast Track designation for MVR-T3011 IT